After the success of last year's conference, SMi is proud to present its 5th annual Adaptive Designs in Clinical Drug Development. This conference is aimed at exploring the potential of adaptive trials now and in the future through looking at the process, from design through to implementation.
Taking place in central London, UK, you will hear presentations from the key players in the adaptive arena on the big questions adaptive design. Is an adaptive design suitable for my needs? What is the regulatory position on adaptive design? How do I build in adaption to my design? Will a seamless design prove any benefit? What are the logistical and practical implications of running an adaptive trial? Where is the future for adaptive designs?
Attend this event to learn what adaptive designs can add to your clinical drug development experience.

What you will learn about:
• Practical considerations for adaptive trials: running an adaptive trial involves certain practical and logistical challenges above a normal trial design - learn how to build these into your trial plan
• Ethical implications: disuss the challenges for Ethics Review Boards when considering an adaptive design - and how to work with the board when submitting an application and during the trial
• Regulation and guidance: how to develop internal regulatory guidance for adaptive trials, and an IBS perspective on the FDA draft guidance
• Design and analysis: presentations and case studies on how to design a successful trial, and how to carry out during- and post-trial analysis

PLUS TWO HALF DAY POST-CONFERENCE WORKSHOPS (AM) Design and Analysis of Adaptive Clinical Trial 1st February 2011, Crowne Plaza - The City, London Led by: Les Huson, Senior Statistical Consultant in Clinical Trials, Statistical Advisory Service, Imperial College London, and Director, GNB Ltd (PM) Finding the Right Dose – Are Adaptive Designs Better? 1st February 2011, Crowne Plaza - The City, London In association with: Cytel